ExamWorks Group Price Target Increased to $32.00 by Analysts at Credit Suisse (EXAM)
Investment analysts at Credit Suisse boosted their price target on shares of ExamWorks Group (NASDAQ:EXAM) from $27.00 to $32.00 in a note issued to investors on Friday, Stock Ratings Network reports. The firm currently has an “outperform” rating on the stock. Credit Suisse’s target price would suggest a potential upside of 26.08% from the stock’s previous close.
A number of other firms have also recently commented on EXAM. Analysts at Needham & Company raised their price target on shares of ExamWorks Group from $31.00 to $33.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Finally, analysts at Zacks downgraded shares of ExamWorks Group from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, September 2nd. They now have a $26.10 price target on the stock.
Shares of ExamWorks Group (NASDAQ:EXAM) opened at 25.38 on Friday. ExamWorks Group has a one year low of $11.27 and a one year high of $24.98. The stock has a 50-day moving average of $26.3 and a 200-day moving average of $22.32. The company’s market cap is $899.5 million.
ExamWorks Group (NASDAQ:EXAM) last released its earnings data on Wednesday, October 30th. The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.08) by $0.02. The company had revenue of $152.40 million for the quarter, compared to the consensus estimate of $151.57 million. During the same quarter in the prior year, the company posted ($0.14) earnings per share. The company’s quarterly revenue was up 17.1% on a year-over-year basis. On average, analysts predict that ExamWorks Group will post $-0.31 earnings per share for the current fiscal year.
ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.